91 related articles for article (PubMed ID: 3447667)
1. Selective decreases in MAO-B activity in post-mortem brains from schizophrenic patients with type II syndrome.
Owen F; Crow TJ; Frith CD; Johnson JA; Johnstone EC; Lofthouse R; Owens DG; Poulter M
Br J Psychiatry; 1987 Oct; 151():514-9. PubMed ID: 3447667
[TBL] [Abstract][Full Text] [Related]
2. Brain and skeletal muscle monoamine oxidase activity in schizophrenia.
Meltzer HY; Jackman H; Arora RC
Schizophr Bull; 1980; 6(2):208-12. PubMed ID: 6103574
[TBL] [Abstract][Full Text] [Related]
3. Elevated postmortem monoamine oxidase B activity in the caudate nucleus in Huntington's disease compared to schizophrenics and controls.
Mann JJ; Kaplan RD; Bird ED
J Neural Transm; 1986; 65(3-4):277-83. PubMed ID: 2940336
[TBL] [Abstract][Full Text] [Related]
4. Brain monoamine oxidase activity in schizophrenics and controls.
Reveley MA; Glover V; Sandler M; Spokes EG
Arch Gen Psychiatry; 1981 Jun; 38(6):663-5. PubMed ID: 7247629
[TBL] [Abstract][Full Text] [Related]
5. [Brain monoamine oxidase in schizophrenia].
Moskvitina TA; Kamyshanskaia NS; Smirnov AV; Prilipko LL; Gorkin VZ
Biull Eksp Biol Med; 1985 Jun; 99(6):671-2. PubMed ID: 4016256
[TBL] [Abstract][Full Text] [Related]
6. Selective reduction of monoamine oxidase A and B in the frontal cortex of subordinate rats.
Dhingra NK; Raju TR; Meti BL
Brain Res; 1997 May; 758(1-2):237-40. PubMed ID: 9203554
[TBL] [Abstract][Full Text] [Related]
7. [Defect in the properties of brain mitochondrial monoamine oxidase in schizophrenia].
Moskvitina TA; Kamyshanskaia NS; Gorkin VZ
Vopr Med Khim; 1986; 32(1):98-102. PubMed ID: 3953020
[TBL] [Abstract][Full Text] [Related]
8. Ontogenesis of monoamine oxidase-A and -B in the human brain frontal cortex.
Kornhuber J; Konradi C; Mack-Burkhardt F; Riederer P; Heinsen H; Beckmann H
Brain Res; 1989 Oct; 499(1):81-6. PubMed ID: 2804672
[TBL] [Abstract][Full Text] [Related]
9. Age-related increases in brain monoamine oxidase B in living healthy human subjects.
Fowler JS; Volkow ND; Wang GJ; Logan J; Pappas N; Shea C; MacGregor R
Neurobiol Aging; 1997; 18(4):431-5. PubMed ID: 9330975
[TBL] [Abstract][Full Text] [Related]
10. Demographic, biologic, and other variables affecting monoamine oxidase activity.
Robinson DS; Nies A
Schizophr Bull; 1980; 6(2):298-307. PubMed ID: 7375862
[TBL] [Abstract][Full Text] [Related]
11. Monoamine oxidase-A and -B activities in the brain stem of schizophrenics and non-schizophrenic psychotics.
Fowler CJ; Carlsson A; Winblad B
J Neural Transm; 1981; 52(1-2):23-32. PubMed ID: 7288435
[TBL] [Abstract][Full Text] [Related]
12. Hydrogen peroxide enhances the activity of monoamine oxidase type-B but not of type-A: a pilot study.
Konradi C; Riederer P; Youdim MB
J Neural Transm Suppl; 1986; 22():61-73. PubMed ID: 3097261
[TBL] [Abstract][Full Text] [Related]
13. Activated MAO-B in the brain of Alzheimer patients, demonstrated by [11C]-L-deprenyl using whole hemisphere autoradiography.
Gulyás B; Pavlova E; Kása P; Gulya K; Bakota L; Várszegi S; Keller E; Horváth MC; Nag S; Hermecz I; Magyar K; Halldin C
Neurochem Int; 2011 Jan; 58(1):60-8. PubMed ID: 21075154
[TBL] [Abstract][Full Text] [Related]
14. Monoamine oxidase-A and B activities in the cerebellum and frontal cortex of children and young adults with autism.
Gu F; Chauhan V; Chauhan A
J Neurosci Res; 2017 Oct; 95(10):1965-1972. PubMed ID: 28151561
[TBL] [Abstract][Full Text] [Related]
15. Platelet monoamine oxidase activity in acute schizophrenia: relationship to symptomatology and neuroleptic medication.
Owen F; Bourne RC; Crow TJ; Fadhli AA; Johnstone EC
Br J Psychiatry; 1981 Jul; 139():16-22. PubMed ID: 7296184
[TBL] [Abstract][Full Text] [Related]
16. Endogenous modulation of monoamine oxidase in schizophrenic and normal humans.
Becker RE; Giambalvo CT
Am J Psychiatry; 1982 Dec; 139(12):1567-70. PubMed ID: 7149055
[TBL] [Abstract][Full Text] [Related]
17. Regional serotonin metabolism in the brain of transgenic mice lacking monoamine oxidase A.
Popova NK; Gilinsky MA; Amstislavskaya TG; Morosova EA; Seif I; De Maeyer E
J Neurosci Res; 2001 Nov; 66(3):423-7. PubMed ID: 11746359
[TBL] [Abstract][Full Text] [Related]
18. Reduced platelet monoamine oxidase activity in a subgroup of schizophrenic patients.
Schildkraut JJ; Herzog JM; Orsulak PJ; Edelman SE; Shein HM; Frazier SH
Am J Psychiatry; 1976 Apr; 133(4):438-40. PubMed ID: 1267046
[TBL] [Abstract][Full Text] [Related]
19. Monoamine oxidase in chronic schizophrenia: Studies of hormonal and other factors affecting enzyme activity.
Murphy DL; Belmaker R; Carpenter WT; Wyatt RJ
Br J Psychiatry; 1977 Feb; 130():151-8. PubMed ID: 319862
[TBL] [Abstract][Full Text] [Related]
20. Brain gamma-aminobutyrate aminotransferase (GABA-T) and monoamine oxidase (MAO) in patients with Alzheimer's disease.
Sherif F; Gottfries CG; Alafuzoff I; Oreland L
J Neural Transm Park Dis Dement Sect; 1992; 4(3):227-40. PubMed ID: 1627256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
